Empagliflozin restores cardiac function in obese-diabetic HFpEF mice but further alters gene expression

• by Juliana Mira Hernandez, Logan R. J. Bailey, Victoria R. Salemme, Christopher Y. Ko, Erin Y. Shen, Megan Ngim, Duong T. Hoang, Melissa Corea, Julie Bossuyt, Jennifer M. Davis, Donald M. Bers, Bence Hegyi

• May 21, 2026

Simultaneous Versus Interval Sleeve Gastrectomy on Patients Requiring Left Ventricular Assist Devices for End-stage Heart Failure: A Retrospective, Single-Center Cohort Study

• by Oscar Olavarria, Syed Naqvi, Luke Crawford, Melissa Felinski, Shinil Shah, Peter Walker, Marwan Jumean, Manish Patel, Ismael Salas, Jayeshkumar Patel, Kha Dinh, Sriram Nathan, Bindu Akkanti, Biswajit Kar, Igor Gregoric, Kulvinder Bajwa

• September 22, 2026

Specific treatment of ATTR-CM in Germany—expert consensus of the German Society of Amyloid Diseases (DGAK) and German Cardiac Society (DGK)

• by Fabian aus dem Siepen, Teresa Trenkwalder, Birgit Aßmus, Ingrid Kindermann, Daniel Lavall, Sebastian Spethmann, Lars Michel, Timon Hansen, Sebastian Kruck, Christoph Rischpler, Fabian Knebel, Stéphanie K. Schwarting, Udo Bavendiek, Maria Papathanasiou, Ute Hegenbart, Ali Yilmaz, Katrin Hahn, Alexander Carpinteiro, Roman Pfister, Caroline Morbach

• September 22, 2026

FDA guidance spurs adoption of change control plans for radiology AI devices

Investigators examined adoption and public documentation of change control plans for FDA-cleared radiology AI devices.

• by Kathryn Wighton

• September 16, 2026

• 3 min